Sana Biotechnology
SANA
SANA
125 hedge funds and large institutions have $770M invested in Sana Biotechnology in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 7 closing their positions.
Holders
125
Holders Change
+9
Holders Change %
+7.76%
% of All Funds
2.16%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
17
Increased
41
Reduced
28
Closed
7
Calls
$92K
Puts
$103K
Net Calls
-$11K
Net Calls Change
-$221K
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$7.13M |
| 2 |
2
Millennium Management
New York
|
$4.87M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$53M |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$21.8M |
| 5 |
ABG
5
Ally Bridge Group
New York
|
$4.41M |
Top Sellers
| 1 |
1
State Street
Boston,
Massachusetts
|
$39.3M |
| 2 |
2
Invesco
Atlanta,
Georgia
|
$231K |
| 3 |
3
Fidelity Investments
Boston,
Massachusetts
|
$55.2M |
| 4 |
PHS
4
PFM Health Sciences
San Francisco,
California
|
$4.15M |
| 5 |
5
Morgan Stanley
New York
|
$4.17M |
